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ABSTRACT
The focus of this study was to investigate the histology of tissue formed when fetal (16-
20 days gestation) and neonatal (2 days old) rat lung cells were grown in a collagen-
glycosaminoglycan scaffold. This project employed a collagen-GAG scaffold
specifically developed for tissue engineering and investigated the effect of this
substratum on the formation of lung histotypic structures in vitro. A cell isolation
procedure was developed whereby 19-days gestation type II alveolar cells reaggregated
i:: v,.tooform alveolar-like structures. The effects of selected scaffold design variables
including pore diameter and degradation rate of the substratum on lung tissue
regeneration were explored. Lung cell behavior revealed as the cells interact with an
analog of the extracellular matrix was also examined. Differences in fetal and neonatal
lung cell behavior were identified using histological analysis. Lung cells were obtained
from Sprague-Dawley rats after 16-, 19-, and 20-days of gestation and at 2 days after
term. These cells were seeded into type I collagen-GAG matrices, sized 8mm in diameter
by 2mm in thickness. The medium used, F12K and Ham's nutrient mixture, was
supplemented with 10% fetal bovine serum. A seeding density between 1 to 5 million
cells per sponge sample was used. Histology studies were performed at termination
periods of 2, 14, and 28 days. This paper describes the in vitro formation and long-term
maintenance of alveolar-like structures from enzymatically dissociated 19-days gestation
fetal rat lung cells cultured on a collagen sponge substrate as a model system for lung
tissue engineering.
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Chapter 1 Introduction and Background
1.1 Purpose of Research
The incidence of lung disease has risen steadily due to the increase in cigarette
smoking, air pollution, and other environmental inhalants. Destructive lung diseases such
as cystic fibrosis, primary pulmonary disease, idiopathic pulmonary fibrosis, and chronic
obstructive pulmonary disease ultimately require lung transplantation. In patients with
lung impairment and limited life expectancy, successful transplantation can significantly
improve their quality of life and prolong survival. About 18 to 20 million people suffer
from chronic obstructive pulmonary disease (COPD) including chronic bronchitis. It is
estimated that 1.6 to 3 million people suffer from emphysema alone, 50,000 people suffer
from idiopathic pulmonary fibrosis, and the same number from cystic fibrosis in the US
[1]. However, due to a fixed pool of lung donors in the midst of a growing patient
population in need of transplantation, about 3:1 transplants needed are provided, so the
waiting period could be more than two years. The result is a stagnant annual lung
transplantation rate and an increase in the number of people who die waiting [2]. In the
US, only about 1,200 lung transplants are performed annually. Despite today's medical
and surgical advances, lung transplantation outcomes still remain poor with a median
survival time of five years [3]. Reasons for its limited success are due to immune-
mediated allograft rejection and secondary complications from immunosuppressive
therapy. It is clear that research and scientific and clinical advances in lung tissue
engineering are greatly needed.
New insights into lung tissue engineering can emerge from an improved
understanding of lung structural development and growth. Since early developmental
events may be determinative of lung sequel later in life, information on fetal and neonatal
lung cell behavior is important. Relatively few cell types play a pivotal role in the
development and maintenance of the normal architecture of the lung so insight into cell-
cell and cell-matrix interactions could provide important information on how the
architecture of the lung is determined.
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1.2 Background
1.2.1 Respiratory system
The main function of the respiratory system is to bring oxygen from the
atmosphere to the blood so that oxygen-rich arterial blood can perfuse organs in the body
and to transport carbon dioxide waste from the tissue to the atmosphere. The system is
divisible into three major parts: ventilation, conduction, and respiration. Ventilation
creates pressure differences that move air into (inspiration) and out of (expiration) the
lungs. The main function of the upper portion of the respiratory system, which includes
the pharynx to the terminal bronchioles, is conduction. This portion warms and
humidifies the air to enhance gas exchange, carries air to and from the site of gas
exchange without collapsing under the pressures generated by the ventilating mechanism,
and also removes particulate matter and micro-organisms.
The lower portion of the respiratory system is specialized for respiration. The
respiratory portion of the lung is distinguished by the presence of alveoli. The actual site
of gas exchange occurs at the alveoli sacs which are composed of clusters of alveoli at the
end of the bronchial tree. Alveolar sacs are comprised of thin alveolar walls consisting
primarily of a central capillary, bounded on each side by simple squamous epithelium.
They are small sacs, approximately 200gm in diameter, which open into respiratory
bronchioles, alveolar ducts, and alveolar sacs. Alveoli are separated from each other by
thin fenestrated walls called interalveolar septae. The fenestrations, called pores of
Kohn, help equilibrate pressures and allow collateral ventilation in the event of a blocked
alveolus. Interstitial connective tissues are also present within the septae. The
connective tissues include: elastic and collagen fibers, ground substance, fibroblasts, mast
cells, macrophages, lymphocytes, and contractile cells which respond to epinephrine and
histamine. The blood-air barrier comprises of the structures that oxygen and carbon
dioxide must cross in the process of gas exchange. In normal lung tissues, it varies from
0.1 - 1.5 im in thickness and includes 1) a film of pulmonary surfactant of the alveolar
surface 2) cytoplasm of the type I epithelial cell 3) the fused basal lamina between the
type I epithelial cells and endothelial cells of the capillary 4) cytoplasm of the capillary
11
endothelial cell 5) plasma of the circulating blood and 6) the erythrocyte plasma
membrane.[4]
1.2.2 Lung anatomy
The trachea bifurcates into two main bronchi which enter the right and left lung
(Figure 1). The right lung is divided into three lobes: upper, middle, lower. The left
lung only has two lobes: upper and lower. The upper left lobe includes the lingual which
is homologous to the middle right lobe. [5]
Figure 1 Gross anatomy of the lung 161
The central airways are considered to be the trachea, right and left main bronchi,
and the major lobar bronchi. The main distinguishing features of the airways are the
presence of cartilage which forms a U-shaped structure anteriorly with the fibrous
posterior membranous sheath. Between the central and distributing airways are
numerous segmental bronchi and subsegmental bronchi. The distributing airways have a
central diameter of 3-4 mm with regular U-shaped cartilage distinguishing them from the
peripheral airways which have abundant smooth muscle in place of irregularly spaced
cartilage. The terminal bronchioles are distinguished from the upper respiratory system
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by their lack of cartilage. Following the terminal bronchioles are the respiratory
bronchioles which contain scattered alveoli. The respiratory bronchioles further divide
into alveolar ducts and alveoli. This branching tree structure of the lung allows the cross-
sectional area to increase from the size of a quarter at the trachea to the size of half a
tennis court at the alveoli (Figure 2). Gas exchange of carbon dioxide and oxygen from
blood to the alveolar air occurs via molecular diffusion at the alveoli. For sufficient gas
exchange, there are over 20 million alveoli in an adult human lung.
Bronchus Bronchiolus AhNeolus
EP
BM
SM
FC
Figure 2 Schematic diagram of the branching structure of the lung (EP: epithelial layer; BM:
basement membrane; SM: smooth layer; FC: fibrous coat). 161
1.2.3 Structure-function relations
The alveolar tissues are mostly composed of elastin and collagen. Elastin is a
cross-linked, random-coil protein that gives lungs their elasticity. The elastic fibers are
arranged in a geodesic network that stretch and store energy during inspiration so that the
lungs can passively deflate and recoil during expiration when the inspiratory muscles
relax. Collagen is a crystallite that gives lungs high tensile strength. The collagen fibers
form a second geodesic network around the alveolar epithelium as tissue stabilizing
forces and prevent the lungs from overinflating.
The alveoli are the main gas exchange units and function to bring oxygen from
the atmosphere to the blood and carbon dioxide from the blood to the atmosphere. Gas
exchange through molecular diffusion is a slow process, and to ensure that there is
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sufficient gas exchange to meet the body's demands, there needs to be maximal surface
area for contact with the blood, minimal diffusion distance between the blood and air, and
well mixing of gases in the lung. The alveoli are structured such that all these
requirements are met. First, each alveolar wall is next to a blood vessel so that the
diffusion distance between the alveolar epithelium to the endothelium is less than 5pim.
Second, a large number of blood vessels line each alveolar space to maximize blood-gas
contact. Third, the size of the each alveolus is only 200gm in size allowing well-mixing
of the gases in the small space.
1.2.4 Histology of the lung
It will be important to identify the critically distinguishing histological features of
the alveoli in order to determine the success in engineering this portion of the lung tissue.
Typically, in vivo, the septae between adjacent alveoli contain a dense network of
capillaries supported by collagen and elastin fibers. This layer of vessels and connective
tissue is covered on either side by an exceedingly thin pulmonary epithelium made up of
type I and type II alveolar cells. In thin portions of the alveoli, the basement membrane
of the endothelium is fused with the basement membrane of the epithelial cells. In
thicker regions, a pulmonary interstitium separates the interstitial space between the
endothelium and the epithelium and contain elastin, collagen, fibroblast-like interstitial
cells, smooth muscle cells, mast cells, and a few lymphocytes and monocytes. The
epithelium is comprised of two types of cells - squamous, attenuated type I alveolar cells
(pneumonocytes) and cuboidal type II alveolar cells. Type I cells function as the site of
gas exchange between the blood and alveolar air and as the site for fluid absorption from
the alveolar space. The role of the type II alveolar cell is in the production of surface-
active phospholipids associated with the pulmonary surfactant system (discussed in
Appendices A.1). Type I and type II alveolar cells make up 10% and 12% of the lung
cell population respectively. Although the number of type I and type II cells are roughly
equal in the alveoli, type I alveolar cells measure approximately 50pim in diameter and
hence cover 95% of the alveolar surface while type II alveolar cells measure
approximately 9utm in diameter and cover less than 5% of the alveolar surface. Alveolar
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macrophages are also loosely attached to the epithelium and lie freely within the alveolar
spaces.
Alveolar epithelial type II cells have microvilli on their apical surface,
osmiophilic lamellar bodies in their cytoplasm, and form intercellular junctional
complexes. Microvilli are covered by a blanket of glycocalyx that consists of delicate
branching filaments of the terminal oligosaccharides of integral membrane proteins that
project from the tip of the microvilli into the lumen. By providing a "diffusion barrier"
the glycocalyx is thought to play a passive role in development of the epithelial barrier
and host defense. However, neither the exact chemical composition nor the exact
function of the glycocalyx is currently known. The osmiophilic lamellar bodies (OLBs)
are a characteristic structural feature of type II cells and are dense granular regions with a
limiting membrane. Its substructure consists of electron-opaque lamellae 26 angstroms
thick with 16 angstroms wide electron translucent zones [7]. These cytoplasmic bodies
are the source of surfactant production in the lung. Type II cells also contribute to
epithelial repair through proliferation, differentiation into type I cells, and elimination of
apoptotic alveolar epithelial type II cells by phagocytosis. Type II cells may also act as
immunoregulatory cells.
Cell-matrix interactions play an important role in cellular function, secretion, and
differentiation. The extracellular matrix (ECM) provides cells with structural support and
modulates cell proliferation, cell migration, attachment, differentiation, and repair. The
ECM of the lung is comprised of collagens, elastin, proteoglycans, glycoproteins, and
basement membranes. Basement membranes are made of type IV collagen and laminin
and separate the epithelium from the stroma. The function of basement membranes is to
provide physical support to the cells resting on them and as a site for cell attachment.
Most importantly, basement membranes are synthesized by the epithelial cells resting on
them. Type I epithelium predominantly overlies a basement membrane comprised of
type IV collagen, laminin, fibronectin, entactin, tenascin, heparan sulfate, and chondroitin
sulfate proteoglycans [8]; whereas type II cells are interspersed in alveolar corners and lie
above type I collagen as well as the other matrix components. In this study, the type I
collagen-GAG matrix is used as a natural analog to the ECM.
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1.3 Hypothesis, Objective, and Specific Aims
From work done by other investigators, type II alveolar cells can reaggregate to
form alveolar-like structures suggesting the possibility for lung tissue engineering [9, 10].
The hypothesis is that lung tissue structures can be regenerated in vitro by fetal or
neonatal rat lung cells grown in a collagen-GAG scaffold. Regeneration of lung tissue is
expected to be histologically similar to lung tissue found in vivo. Lung tissue developed
in vitro should have both alveolar type I and II cells, and cells should secrete extracellular
matrix components found in the lungs. Both type I and II cells should also be
morphologically similar to typical alveolar pneumonocytes. Type I cells are expected to
be squamous, thin, with an attenuated nuclei, and type II cells are expected to be
cuboidal, with characteristic osmiophilic bodies which secrete pulmonary surfactant.
The objective of this thesis project is to develop an in vitro system for the
regeneration and long-term maintenance of lung tissue structures cultured in a collagen-
GAG scaffold suitable for lung tissue engineering. The long-term goal is to develop a
collagen-GAG scaffold as an implant to be used alone or seeded with cells for the
regeneration of lung tissue in vivo.
Specific aims for this project include:
1. Development of a cell isolation procedure whereby cells are
enzymatically dissociated from fetal and neonatal rat lungs while
maintaining cell surface receptors which are critical in regeneration of
lung structures.
2. Investigation of the effects of selected scaffold design variables on lung
tissue regeneration in our in vitro system.
3. Investigation of lung cell behavior revealed as the cells interact with an
analog of the extracellular matrix.
4. Identification of differences in fetal and neonatal lung cell behavior
using histological analysis.
16
Chapter 2 Review of Past Work
2.1 Cell Source
Cells isolated from fetal rats appear to play an important role in the ability of type
II alveolar cells to proliferate in tissue culture. In previous work, type II cells isolated
from adult animals have exhibited minimal proliferation in tissue culture, and the
addition of growth factors did not increase cell number. Confluent monolayers of adult
type II cells formed by cell flattening and spreading rather than by cell division. Most in
vitro studies reported only increases in DNA synthesis and changes in phenotype in the
absence of proliferation. ECM preparation from bovine corneal endothelial cells and
various soluble factors (rat serum, epidermal growth factor, insulin, cholera toxin)
stimulated [3 H]thymidine incorporation, cell labeling, and DNA content. However, these
agents did not affect cell proliferation since no increase was found in cell number.
Unlike type II cells isolated from adult animals, fetal lung cells obtained from cultures of
dissociated alveolar-like structures have been reported to have the capacity to proliferate.
2.2 Isolation Methods
There have been several in vitro techniques for the dissociation of lung tissue into
a cell suspension used by various investigators. In particular, most investigators have
focused on techniques to yield a purified population of alveolar type II epithelial cells for
the purpose of studying pulmonary surfactant secretion.
One method of isolating type II epithelial cells is by differential adherence.
Differential adherence in monolayer culture is used to separate epithelial cells from other
cells found in the lungs. Fibroblasts typically adhere first to tissue culture surfaces,
followed by macrophages and endothelial cells, and then type II cells. In the presence of
serum, type II cells adhere more rapidly than most lymphocytes. The time period for
type II cell adherence ranges between 3-48 hours. Therefore, a cell suspension of type II
cells in high yield can be obtained by first plating the primary cell suspension on a tissue
culture plate for one hour to remove most fibroblast cells, and then replating the non-
adherent cell suspension and medium onto a new dish and culturing for one hour to
17
remove the endothelial cells and macrophages. After this second culture period, the
medium and non-adherent cells can be resuspended and cultured for 1-2 days to allow the
epithelial cells to adhere. In this manner, type II cells in greater than 90% purity can be
obtained from 19-day fetal lungs [11, 12].
Another method for isolating type II epithelial cells is by using elastase,
Immunoglobulin G, and "panning." Enzymatic digestion of lung tissue with trypsin or
collagenase liberates alveolar cells as well as both interstitial and endothelial cells.
Elastase is therefore used by other investigators to selectively loosen or remove the
alveolar epithelium from the underlying basal lamina. It has also been documented that
cell yield can be improved when elastase is used in addition to trypsin (50pg/ml
crystalline trypsin is added to elastase 30 orecein/elastin U). The use of elastase instead
of or in addition to trypsin is believed to better preserve an intact cellular membrane
function [6]. IgG is plated onto the flasks for further selective removal of macrophages,
leukocytes, fibroblasts, and non-type II cells [ 10, 13]. Since epithelial cells lack the Fc
receptor which binds IgG, the adherent fibroblasts, macrophages and lymphocytes can be
selectively removed.
2.3 ECM analogs used
Alveolar-like structures have been observed in previous work done using Gelfoam
sponges [14], endothelial matrices [15], Matrigel, and floating collagen gel membranes
[16]. Gelfoam sponges are made of gelatin and Matrigel is an epithelial basement
membrane material rich in collagen IV and laminin. No information was given about the
specific type of collagen in the Gelfoam sponges or floating collagen gel membranes
used. In addition, other matrices previously used include rat tail collagen gels [16],
human amniotic membrane [17], fibroblast feeder layers on collagen gels, preparations of
alveolar basement membrane [17], and gels made of Engelbreth-Holm-Swarm (EHS)
tumors [18].
2.4 Formation of Alveolar-Like Structures
Formation of alveolar-like structures composed of type II alveolar cell aggregates
have been found by several investigators. One of the earliest documentation describing
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the formation of these structures was by William Douglas in 1976 [9, 19, 20]. Douglas et
al. observed the formation of histotypic structures from monodispersed fetal rat lung cells
cultured in a three-dimensional Gelfoam sponge. He used lung cells obtained from 19-21
days gestation Sprague-Dawley fetal rats. The alveolar-like structures formed were noted
to be composed of type II cell aggregates surrounding a central lumen [14]. The type II
cells were cuboidal with lamellar bodies and intercellular tight junctions, and exhibited
polarity with apical microvilli facing the lumen, basally located nuclei, gel matrix
abutting the basal surface, and the cells secreted pulmonary surfactant confirmed by
presence of osmiophilic lamellar bodies [7].
Sugihara et al. more recently also observed the reconstruction of alveolar-like
structures from alveolar type II epithelial cells when cultured in a three-dimensional
collagen gel matrix [10]. Lung cells were obtained from 21- to 23-days-old Wistar rats.
A different method of isolation was used where elastase was used in tissue digestion.
Cells were seeded by mixing the isolated suspension with a soluble type I collagen
solution and warmed to form a gel. Sugihara et al. found that isolated type II cells
reconstructed to form large alveolus-like structures composed of cells described
morphologically as type I and type II cells.
In another study, investigators were able to obtain alveolar-like structures within
20 hours of cultures. Fetal rats between 18 to 22 days gestation were used. Lungs were
dissected from the fetuses, minced, and then dispersed into a cell suspension using 0.05%
trypsin and I O10g/ml DNase. Single cells were obtained by filtering the cell suspension
through a 50pm Nitex filter. The cells were pelleted by centrifugation, incubated for 1
hr. at 37°C to allow reaggregation, and then resuspended in minimal essential medium
(MEM) containing 10% fetal calf serum, 501pg/ml gentamycin, and 2.5p1g/ml
amphotericin B. An aliquot (75pl) containing approximately 107cells was inoculated
onto cm2 piece of medium hydrated Gelfoam and incubated overnight in 100mm Petri
dished (10 - 15 pads per dish) containing 10ml of culture medium at 37°C in 5% CO 2 in
air. Under these conditions, type II cells reaggregated as alveolar-like structures. [21 ]
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Chapter 3 Materials and Methods
3.1 Fabrication of Type I Collagen-GAG Scaffold
The general paradigm of tissue engineering is to use a cell source, biomaterial
scaffold, and bioreactor. Typically, cells (from living tissue or endogenous cells of the
host) are seeded within a two-dimensional or three-dimensional biomaterial and cultured
within a bioreactor to regenerate tissue in vitro which is then implanted in vivo as a
reparative therapy to replace lost tissue and function. The biomaterial used is a scaffold
that can be composed of natural polymers or synthetic polymers. Natural materials
include proteins, such as collagen, fibrin, silk, and polysaccharides such as
glycosaminoglycan and dextran. Synthetic polymers include poly(a-hydroxyesters) such
as poly(glycolic acid), poly(L-lactic acid), poly(lactic-co-glycolic acid), or hyaluronan
derivatives. The scaffold plays a key role in tissue engineering and provides a three-
dimensional environment for the cells. Ideally, the scaffold represents an analog of the in
vivo extracellular matrix structurally and chemically at the molecular, micro-, and macro-
level.
Collagen is a triple helical protein abundant in the connective tissues of the body
(Figure 3). Its primary structure is a polypeptide chain (Gly-X-Y)n rich in proline and
hydroxyproline with glycine at every third amino acid allowing the polypeptide to
undergo rotation. The secondary structure is helical due to the hinge-like glycine and
stiff hydroxyproline units. Three secondary helical polypeptides form the tertiary triple-
helical collagen molecule which is 1.5nm in diameter and 300nm in length and bundle
into microfibrils 4nm in diameter. These microfibers then bundle into fibers 0.5,Am in
diameter. The quaternary structure of collagen is highly specific forming a crystalline
fiber with a banding pattern of 64-nm periodicity (Figure 4). Collagen's functions
originate from its unique primary to quaternary structure and its architecture. Advantages
of collagen scaffolds are their very mild inflammatory response across species, high
porosity, controllable pore size, and degradation by tissue collagenases. Limitations to
collagen scaffolds include mechanical instability compared to stronger scaffolds (silk,
polymers), contraction over time due to dehydration of collagen fibrils, structural
heterogeneity, and possible pathogen transfer.
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Highly porous scaffolds are used in tissue engineering to provide both a three-
dimensional environment for cells and a high surface area to allow cell attachment and
cell-scaffold interactions. The porosity and pore size of the scaffold determine the area
available for cell attachment, migration, and mass transfer. It has been shown that cell-
scaffold interactions play an important role in cellular activity and processes. Optimally,
in order for the scaffold to promote cell adhesion and cell growth, the chemical
composition of the scaffold should contain ligands that allow cell adhesion and have pore
sizes large enough for cells to migrate in. The scaffold should also be highly porous so
that nutrients and metabolites can diffuse freely through. Typically cells are 90-99%
porous with pore diameters that range 5-500pim.
The scaffold also needs to satisfy conditions for in vivo implantation. The
scaffold must not only promote cell activity in vivo, but must also be biocompatible in the
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body and biodegrade to minimize long-term immunogenicity. The degradation rate of
the scaffold in vivo should match the rate of tissue regeneration so that the scaffold only
serves as a cell delivery device or provides mechanical structure during the duration of
critical cellular processes and then degrades into biocompatible products. The scaffold
degradation time is dependent on many variables including degree of cross-linking,
mechanical factors, molecular and structural characteristics of the scaffold, cell-seeding
density, and the extracellular environment.
The scaffold fabricated in this study allows the transport of cells and metabolites
through a large pore volume fraction and an interconnected pore network. High cell
attachment is achieved through a high specific surface area (high surface area to volume
ratio), which is dependent on scaffold pore size, pore shape, and pore volume fraction.
Ideally, the optimal fabrication should produce a scaffold that is homogenous in pore size
and shape.
3.1.1 Fabrication of scaffold
Type I collagen-glycosaminoglycan scaffold was fabricated from type I slurry
using a freeze-drying method [22]. The suspension was made from dry type I collagen
isolated from bovine tendon (Integra Life Sciences, Plainsboro, NJ), chondroitin-6-sulfate
isolated from shark cartilage (Sigma Aldrich Chemical Co., St. Louis, MO), and 0.05M
acetic acid (pH 3.2). The final suspension contained 0.Swt% type I collagen, and
0.05wt% chondroitin-6-sulfate. The slurry was first cooled to 4°C to prevent
denaturation of collagen fibrils, and then mixed with a blender at 15,000rpm. The final
suspension was degassed at a pressure -50mTorr for 90 minutes to remove air bubbles
created with the blender before freeze-drying.
A volume of 67.25ml of degassed collagen-glycosaminoglycan (GAG)
suspension was used to fabricate one sheet of scaffold 12.4 x 12.4cm. The suspension
was first equilibrated to 200C within the freeze dryer oven for 5 minutes. The
temperature of the freeze dryer chamber was then reduced and ramped down to -400 C to
produce solidified collagen-GAG co-precipitate localized between nucleated ice crystals.
This network of ice and co-precipitate was then annealed at that temperature for a
minimum period of 60 minutes to allow the ice crystals that nucleated to grow. After this
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annealing period, the ice crystals were sublimated under vacuum (<10 mTorr) at 0°C for
17 hours to leave behind a highly porous solid type I collagen-GAG scaffold.
3.1.2 Pore Size and Porosity
The fabrication protocol described above creates a collagen-GAG scaffold with
uniform porosity of 99.5%. The pore size of the scaffolds can be altered by changing the
annealing temperature and ramping time. Larger average pore sizes can be created by
increasing the annealing temperature, decreasing the ramping time, and decreasing the
total time from start to sublimation. In this manner, larger ice crystals can be formed and
sublimated producing a scaffold with a larger average pore size. In the studies done,
scaffolds with an average pore size of 95.9±12.3[tm, 99.5% porosity, and a specific
surface area (S.A./Vol) of 0.00748gm' were used as well as scaffolds with an average
pore size of 109.5+18.3pm, 99.5% porosity, and a specific surface area of 0.00655pm1m'.
The table below provided by Brendan Harley [22] reflects the effect of time and
temperature on pore size.
Table 1 Scaffold Pore Size vs. Ramping Time and Temperature
Average Pore Size (m) Ramping & Annealing Ramping Time (min)
Temperature (o C)
95.9+12.3 -40 15
109.5±18.3 -30 10
121.0±22.5 -20 10
150.5±32.1 -10 5
3.1.3 DHT cross-linking
The collagen-GAG scaffolds were dehydrothermally (DHT) cross-linked to
increase the mechanical properties of the structure. Scaffolds were cross-linked under
vacuum at 50mTorr at 105C for 24 hours in a vacuum oven (Fisher IsoTemp 201, Fisher
Scientific, Boston, MA). DHT-treatment of scaffolds covalently cross-links the
polypeptide chains of the collagen fibers without denaturing the collagen into gelatin.
Treatment of the scaffolds at high temperature also renders the scaffold sterile without
changing its physical and chemical structure.
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3.1.4 EDAC cross-linking
To decrease the degradation rate of the collagen-GAG scaffolds, scaffolds were
chemically cross-linked by -ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDAC)
cross-linking. DHT-treated matrices were first hydrated with half the total final volume
of EDAC (MW = 191.7g/mol; Sigma Aldrich Chemical Co., St. Louis, MO) and N-
hydroxysuccinimide (NHS) (MW = II 6g/mol, Sigma Aldrich Chemical Co., St. Louis,
MO). 6mmol EDAC/g collagen was used with a 5:2 molar ratio of EDAC: NHS
dissolved in distilled water. Matrices were chemically cross-linked at room temperature
for 15 to 20 minutes, washed with Hank's Balanced Salt Solution, and rocked on a
nutator for at least an hour to remove residual NHS/EDAC solution. Matrices were
rinsed in sterile deionized water before use.
3.1.5 Experimental preparation
Type I collagen-GAG sheets (12.4cm x 12.4cm x 2cm) were punched from the
dry sheets of the scaffold samples, 8mm in diameter x 2 mm in thickness, using a sterile
dermal punch (Barron Vacuum Trephine, 8mm, Katena Products). Prior to cell-seeding,
matrices were hydrated in sterile deionized water and rocked on a nutator to remove any
bubbles for at least an hour at room temperature. Matrices were then hydrated in warmed
(37°C) media before direct cell-seeding.
3.2 Isolation of Rat Alveolar Cells
3.2.1 Cell Source
For this thesis, lung cells were obtained from the following animals with the
approval of the VA Animal Care Committee: 10-day-old mice, 16 to 20-days gestation
fetal rats, and 2-day-old neonatal rats. The 10-day-old mice were provided by Boston
University. Neonatal and fetal lung cells were obtained from timed-pregnant Sprague
Dawley outbred rats (Taconic, Germantown, NY). It is still not possible to determine
with complete accuracy the time of conception. However, the time of egg and sperm
fertilization can be determined within a 24-hour window of accuracy by detection of
sperm in the female. By convention, fertilization marks the beginning of day of
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gestation. Fetal rats 19 days of gestation mark 18 days after the day of conception.
Typically, the term averages 22 days but can range between 21-23 days. The
developmental stages of fetal rats have been well documented. By day 19, the embryo
has undergone nearly complete maturation, eye lids are formed and fused (day 15), joint
cavities have developed for the shoulder, elbow, hip, and knee joints (day 16), for the
carpal and tarsal joints (day 17), and for the digital joints of the legs (day 19). At 19 days
of gestation, all blood activity still occurs in the liver. By day 22, blood forming activity
in the liver ceases with the end of gestation. At birth the crown to rump length of the
fetus ranges from 40.5mm to 42.6mm and weight 5.9 - 6.4g.[23]
3.2.2 Methods for Cell Isolation Procedure
The isolation of rat alveolar cells from the lung tissue is a critical process to the
reaggregation and regeneration of cells into alveolar-like structures. Successful structural
formation and lung tissue regeneration is not only dependent on its environment but also
on the retention of cell surface receptors that enable cell recognition and migration.
Improper tissue dissociation methods can damage cell surfaces, destroy these receptors,
and ultimately reduce cell viability. Hence, the method used in this study is documented
in detail.
3.2.2.1 Dissection
Lungs cells were isolated using a modified method from work done by Douglas et
al [24]. A timed-pregnant female rat (Taconic) was first sacrificed by CO2 asphyxiation
between 19-20-days gestation. A hysterectomy was then performed and the fetuses were
aseptically removed from the uterus and washed with Hank's Balance Salt Solution
(HBSS) (Gibco). The fetuses were dissected free of the placenta and attendant
membranes, and the umbilical cords were cut. After washing with fresh HBSS, the
thoracic cavity was exposed and the lungs were perfused with 3ml of HBSS via a 27-
gauge needle placed in the right ventricle until the blood cleared and was then excised.
Lungs were then removed from each fetus and washed in serum-free Kaighn's modified
F12K medium.
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3.2.2.2 Tissue Homogenization and Digestion
Lung tissues were first minced into mm3 pieces using a sterile razor blade under
sterile conditions. Tissue was then digested using 30ml of sterile CTC enzyme solution
containing 0.1% type I collagenase [155units/mg] (Gibco), 0.1% trypsin buffer (Sigma),
1% chicken serum in IX calcium and magnesium-free Dulbecco's phosphate-buffered
saline (Gibco) and 500pl RNase-free DNase [000units/ml] (Promega) with 29.5ml of
HBSS (Gibco). DNase was used to prevent the polymerization of DNA released from
damaged cells. This solution was placed on a shaker and incubated for 15 minutes at
300rpm, 37°C. The dissociation fluid was filtered through a 41 gm-pore size mesh. The
remaining tissue was washed with serum-free F12K media filtered through the mesh.
Lung tissue and solution were stored on ice to lower cellular metabolism and prevent cell
autolysis. Fetal bovine serum (FBS) was added to inactivate the collagenase and trypsin.
An additional 30ml of CTC enzyme solution and 1000units DNase was then added to the
undigested tissue and the solution was incubated on a shaker for another 15 minutes at
300 rpm, 37°C. The digested solution was also filtered through the 41 m-pore size mesh
(Spectra mesh, VWR). F12K supplemented with 10% fetal bovine serum (FBS) was then
added to inactivate the trypsin and collagenase for a final volume of 50ml. The harvested
cell suspension was centrifuged for 10 minutes at 1500rpm and the supernatant removed
leaving several milliliters of supernatant medium. Cells were resuspended by mild
Vortex mixing and the solution was then passed through a 251im filter (Spectra mesh,
VWR). This homogenate was centrifuged for 10 minutes at 1500rpm and the supernatant
discarded leaving a thin layer of medium above the pellet. The cell pellet was incubated
at 37°C for 1 hour. (Refer to Protocol A.2 in Appendix section for more details.)
Lung cells were isolated from mice and neonatal rats by a method similar to that
described above. However, mice and rats were first anesthetized intraperitoneally with
0.15ml of sodium pentobarbital.
3.3 Cell seeding and Culture
Prior to cell seeding, a viable cell count was first performed using trypan blue
exclusion. Cells were seeded using the pipette method. The F12K or Ham's media
(Gibco) used was supplemented with 10% fetal bovine serum (Gibco), 1% antimyotic
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(Gibco), and 2% penicillin-streptomycin-glutamine (Gibco). Following the one hour
incubation period, cells were resuspended in medium to give a final concentration of
108cells/ml. Cells were seeded with a cell-seeding density of 5xl 06cells/matrix or with a
minimum of Ix 1O6cells/ matrix in agarose-coated 12-well tissue culture plates. Each side
of the matrix was inoculated with 20g1l of cell suspension or complete media for the
controls. Matrices were incubated for 10 minutes and the other side was then inoculated
with an equal amount of cell suspension or complete media. Matrices were then
incubated for 2-3 hours to allow cells to attach to the substrate before adding 0.5ml of
complete media. After 24 hours, 1.5ml media was added to each well, and after 48 hours,
cultures were placed on a rocker platform at a speed of 6 cycles per minute. Complete
medium is replaced every 2-3 days.
3.4 Histology & Immunohistochemistry
3.4.1 Fixation
Matrices were removed from media and fixed in 10% neutral buffered formalin
for a minimum period of 24 hours before processing. Fixation is needed to prevent
autolysis and preserve cells and tissues permanently in as life-like state as possible.
Formalin (formaldehyde) is an aldehyde which fixes tissues by reacting primarily with
basic amino acids to form cross-linking methylene bridges without significantly altering
the structures of intracytoplasmic proteins. Buffer is used to prevent acidity that would
promote cell autolysis and precipitation of formol-heme pigment in tissues.
3.4.2 Processing, Embedding, Sectioning
Samples were processed to get fixed-tissue into paraffin. Processing was done
using an automated tissue processor. During processing, matrices were dehydrated using
ethanol and cleared using xylene. After processing, samples were embedded in paraffin
and sectioned 7pm thick using a microtome.
3.4.3 Staining
To prepare matrices for staining, samples must first be deparaffinized to allow
water soluble dyes to penetrate. Samples were deparaffinized in xylene and then
27
rehydrated in 100%, 95%, 80%, and 70% ethanol and stained. Samples were then
dehydrated in 80%, 95%, and 100% ethanol, xylene, and coverslipped (mounting media
Cytoseal 60).
3.4.3.1 Hematoxylin & Eosin
To observe the presence of cells in the matrices, hematoxylin & eosin stain was
used. Hematoxylin is a basic dye that stains blue-purple and eosin in an acidic dye that
stains pink-red. Eosin stains proteins and cytoplasm while hematoxylin stains anything
negatively charged including the nucleus and DNA. Differentiation between type I and II
alveolar cells can also be determined through hematoxylin and eosin staining. Type II
alveolar cells should appear cuboidal in shape with microvilli on their apical surface
while type I alveolar cells should appear attenuated and squamous and lack microvilli.
3.4.3.2 Smooth muscle actin
Smooth muscle actin is a protein filament important to cell contraction and
migration. Myosin-actin interactions are responsible for generating tensile and
contractile forces within the cell. Immunohistochemistry is performed to detect presence
of a-smooth muscle actin in cell-seeded scaffolds.
Samples were first deparaffinized in xylene and rinsed in absolute alcohol
followed by distilled water. Sections were then incubated in TRIS/HCI buffered saline,
pH 7.6 (TBS) followed by 3% hydrogen peroxide (H202) solution to quench endogenous
peroxidase activity and reduce background staining. Slides were washed with TBS
before adding protein blocking agent (PBA) to reduce non-specific antibody binding.
Sections were incubated in primary a-smooth muscle actin antibody for 1 hour. After
washing in TBS, biotinylated secondary antibody was added. After one wash with TBS,
peroxidase reagent was added followed by a second wash with TBS. Sections were then
incubated in DAB developer solution, washed in TBS and counterstained in hematoxylin.
3.4.3.3 Cytokeratin
Cytokeratin is an intermediate filament specific to epithelial cells and can be used
to differentiate epithelial cells from cells of other origins. Immunostaining for
monoclonal antibody to cytokeratin is used to identify epithelial cells. Cells are stained
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for cytokeratin using anti-cytokeratin solution diluted 1:5 in using a similar method
described in 3.4.3.2. Type II cells are known to be positive for monoclonal antibody to
cytokeratin no. 19 and type I for cytokeratin no. 18 [21].
3.4.3.4 Elastin
Elastin is abundant in the extracellular matrix of the lung in vivo. Dye to identify
the presence of elastin is made using I g hematoxylin powder, I 00ml of 100% ethanol
and ferric chloride. The dye is differentiated using saturated picric acid and van Gieson
stain is used to provide contrast.
3.4.3.5 Masson Trichrome
Masson Trichrome is a connective tissue dye. It is a three dye stain that stains the
cell nuclei black, the cell cytoplasm red, and collagen blue.
3.5 Experimental Design
To study the influence of the extracellular matrix on lung tissue engineering, both
DHT-treated and EDAC-treated matrices were initially used. EDAC matrices prevent
contraction, have a lower degradation rate, and provide a stronger substratum support for
cells. DHT-treated matrices have a higher degradation rate and are more similar to the
Gelfoam matrices or floating collagen membranes previously used in other work. Using
two types of matrices allows exploration of the importance of contraction and the effect
of degradation rate on the formation of alveolar-like structures.
3.5.1 Mice studies
Two studies were performed using lung cells obtained from newborn mice 10-
days-old. In the first study, lung cells from 13 pups were obtained, and in the second
study, lung cells were obtained from 11 pups. Cell isolation procedure is described in
Chapter 3. Mice were provided by Boston University. Cells were seeded into both
DHT-treated (105°C, 24hrs) and EDAC-treated type I collagen-GAG matrices. Type I
collagen-GAG matrices had an average pore size of 95.9±12.3pm, porosity of 99.5%, and
specific surface area of 0.00748pm' l. Matrices were pre-hydrated before seeding by the
pipette method. Following the study by Douglas[20], a cell-seeding density of
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5xl0 6cells/matrix was used. Due to a fewer number of cells obtained in the second study,
a cell-seeding density of 2.6xl06cells/matrix was used. Samples were sacrificed and
examined at 7 days, 14 days, and 21 days. The media used in cultures was DMEM/F-12
(Gibco) supplemented with 10% FBS and antibiotics.
3.5.2 Neonatal rat studies
Neonatal rats of Sprague Dawley strain (Taconic) were sacrificed when they were
2-days-old. Lung cells were obtained from a total of 13 rats. To increase the cell
number, cells from 6 rats were plated and cultured for I week before seeding. Primary
lung cells from 5 rats were directly seeded into collagen-GAG matrices. A total of 12
DHT-treated matrices were used with an equal number of experimental samples and
controls. Type I collagen-GAG matrices had an average pore size of 95.9±12.3pm,
porosity of 99.5%, and specific surface area of 0.00748gm' l. Matrices were pre-hydrated
before seeding by the pipette method. The cell-seeding density determined prior to
seeding was 3.07 x 10 6cells/matrix. Samples were sacrificed after 1 week, 2 weeks, and
3 weeks. The tissue culture was placed on a rocker platform and culture was rocked
between 3-6 cycles/min to increase perfusion of nutrients and media through the matrix.
Samples were analyzed by scaffold contraction, histology, and immunohistochemistry.
3.5.3 Fetal rat studies
Lung cells were isolated from fetal rats at 19 to 20-days gestation because this is
during the saccular phase of lung development where respiratory endings expand to form
saccules and differentiation between type I and II alveolar cells begin. However, due to
continuing differentiation of cells at an unknown rate, the gestational age of the cells in
the final culture cannot be related to that of the animals from which they were isolated.
3.5.3.1 16 days gestation
An initial study was performed using cells from fetal rats at 16-days gestation.
Observations of lung cell behavior at 16-days gestation can be compared with cells
obtained at a later gestational age to find the effect of gestation age on lung cell behavior.
Lung cells were isolated from twelve fetal rats (Sprague Dawley, Taconic) at 16 days of
gestation. Both DHT-treated matrices (n=4) and EDAC-treated matrices (n=4) were used
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with a cell-seeding density of 2.3 x 106cells/matrix. Type I collagen-GAG matrices had
an average pore size of 99.5±12.3 gm, porosity of 99.5%, and specific surface area of
0.00748gm'. Matrices were pre-hydrated before seeding by the pipette method. Cultures
were placed on a rocker after 48 hours at 6 cycles/ min. Samples were sacrificed after 1
week, 2 weeks, and 3 weeks. H&E and cytokeratin samples were examined using light
microscopy.
3.5.3.2 19 days gestation
Lung cells were isolated from six timed-pregnant Sprague-Dawley rats and a total
of 92 lungs were obtained. In this study, a total of 77 type I DHT-treated collagen-GAG
scaffolds with pore size of 95.9±12.3ipm. There was a total of 35 type I collagen-GAG
cell-seeded matrices and 42 type I collagen-GAG controls. From data given by Douglas,
we expected lung tissue from 100 19-20 days gestation fetuses to have a wet weight of 5g
and a total of 175-200x107cells. Cells were isolated following the protocol described in
Chapter 3. Matrices were seeded with a density of 3.98 xl07cells/matrix. Samples were
sacrificed at 2 days, 2 weeks, and 3 weeks and analyzed histologically (n=3). A DNA
assay was also conducted to determine cell activity and proliferation (n=6).
Another study was conducted using the same variables described above with three
timed-pregnant Sprague-Dawley rats and a total of forty-one 19-days gestation rats;
however, matrices were seeded dry rather than hydrated. It was believed that while pre-
hydrating the matrices had the advantage of removing bubbles within the matrix, if the
matrix was saturated it would prevent cells from migrating in. In this study, the scaffold
used were type I collagen-GAG with a pore size of 95.9±12.3pm. The tissue culture
plates were placed on a rocker at 6 cycles/ min after 2 days for the remaining time in
culture. From a cell-count performed, there were a total of 208.12x1 06 cells including the
red blood cells. The cell-seeding density used was therefore 10.41xl 06 cells/matrix.
Cells were seeded into dry matrices using an aliquot of 40Pl/matrix. The media used in
this study was Ham's F12 media supplemented with antimycotic, penicillin, and 10%
FBS. A total number of 38 scaffolds were used. Sample size for this study was n= 6
with an equal number of controls. Cells were analyzed by H&E, SMA, cytokeratin, and
elastin histology stains.
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3.5.3.3 20 days gestation
A study was conducted using fetal rats at 20-days-gestation. Lungs from a total
of 35 fetuses were isolated. DHT-treated type I collagen-GAG matrices were used and
samples were sacrificed at 3 days, 9 days, 2 weeks, and 3 weeks. Type I collagen-GAG
matrices had an average pore size of 109.5+18.3pm, porosity of 99.5%, and specific
surface area of 0.00655gm-l. Matrices were pre-hydrated before seeding by the pipette
method. In this study, passaged cells and primary cells were used. In passaged cells, cells
were cultured for 4 days before trypsinized and used for seeding. From a cell count
performed, there were 17.52x106 passaged cells with 74% viability and 8.96x106 primary
cells. A cell-seeding density of 1.12 x 106 cells/matrix was used for seeding with primary
cells and a cell-seeding density of 9.7 x 105cells/matrix was used for seeding with
passaged cells. The difference in number reflects the number of red blood cells in the
primary cell suspension that were directly seeded into the matrices as well. The entire
study had a total of 34 cell-seeded matrices and 34 control matrices. Samples were
sacrificed and analyzed for contraction, H&E, cytokeratin, SMA, and DNA.
3.6 DNA Assay
Samples were assayed for DNA to determine the cell count and cell proliferation
activity. Samples were first lyophilized in the lyophilizer machine under vacuum below
133x10-3mbar overnight before digestion using 0.125mg papain (Sigma) per 6.25mg
sample at 600C overnight. Papain buffer solution was composed of 2.45ml dibasic stock
solution, 17.54ml monobasic stock solution, 80ml distilled water, 87.82mg L-cysteine
HCI, 186.12mg disodium ethylenediamenetetraacetate (EDTA, Fisher) adjusted to a pH
of 6.2. Aliquots of papain digested samples were read fluorometrically using 1:200 pico-
green dye dilution (Perkin Elmer Victor2 , xcitation = 485nm, Xemission = 535nm, 1.Os). The
amount of DNA was then quantified by extrapolation from a standard curve of calf
thymus DNA.
3.7 Collagen-GAG Assay
A collagen-GAG assay was performed to find any glycosaminoglycan content in
the cultures. Samples were prepared in the manner similar to preparation for the DNA
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assay. Aliquots of papain digested samples were read fluoremetrically using dimethylene
blue. The amount of GAG was then quantified by extrapolation from a standard curve of
shark chondroitin sulfate in dH20.
3.8 Quantification for Alveolar-like structures
The formation of alveolar-like structures was quantified using Scion Image (Scion
Corporation; Frederick, MD). Since most of the alveolar-like structures were more
elliptical than circular, two measurements were made in determining the size of the
structures. The minor axis was defined as the smallest measured diameter and the major
axis was defined as the largest diameter measured. Another term, the form factor, was
defined as the ratio between the major and minor axis which can range between 0 and 1.
A structure resembling a circle would have a form factor of I while the more elliptical the
structure was, the closer the form factor would be to 0. The average size of the alveolar-
like structures was taken to be the average between the major and minor axis, or the
average between the largest and smallest diameters.
3.9 Pore Characterization
Scaffolds were embedded in paraffin, sectioned 7g1m thick, and stained using
hematoxylin and eosin. Samples were visualized on an optical microscope and digital
images were taken using a color video camera. Images were first edited on Adobe
Photoshop. Pore size of scaffolds was characterized from digital images using a linear
intercept method macro from Scion Image image analysis software (Scion Corporation;
Frederick, MD). The linear intercept method constructs a best-fit ellipse to analyze the
average pore cross-section. The major and minor axes of the ellipse are multiplied by a
factor of 1.5 to correct for pores that are not sectioned at the maximal cross-section but at
an arbitrary angle. The average of the major and minor axes of the best-fit ellipse is
defined as the mean intercept length. The mean pore diameter of the scaffold at each
position within the scaffold is calculated from the average of the mean intercepts in the
longitudinal plane and in the adjacent traverse plane [22].
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3.10 Sample Size
The sample size for the analyses used was (i.e., n=6) based on the desire to
determine as significant as 20% difference between experimental groups (control vs. cell-
seeded) each with a 10% coefficient of variation when evaluating selected parameters
(e.g., the number of alveolar-like structures formed per collagen-GAG sponge, scaffold
contraction). A 15% standard deviation is assumed and alpha=0.05 and beta0. I1 is
employed. Experiments were run in duplicate. Analysis of variance (ANOVA) was used
to determine the effects of selected treatments on the outcome variables, followed by
Fisher's least squares protected difference (LSPD) post-hoc test to compare specific
groups.
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Chapter 4 Results
4.1 Sample Size
A summary of the number of fetuses and neonates isolated from timed-pregnant
Sprague-Dawley rats are shown in Table 2. Primary cells or both primary cells and
secondary (passage 1) cells were used in the studies as indicated. The number of cell-
seeded constructs sacrificed for histological analysis in each study is shown in Table 3.
Cell-seeded samples were also for DNA analysis in studies using 19-days and 20-days
gestation fetal rat.
Table 2 Number of timed-pregnant Sprague-Dawley rats and corresponding fetuses or neonates
sacrificed for lung cells in each study.
Timed-Pregnant Fetuses Passage
Rats
16-days gestation 1 12 Primary
19-days gestation 9 133 Primary
20-days gestation 3 35 Primary and P1 
2-days neonatal 1 13 neonates Primary and P1
Table 3 Number of cell-seeded type I collagen-GAG scaffolds sacrificed for histological and DNA
analysis in each study.
DHT cross-linked EDAC cross-linked
2 days 1 wk 2 wks 3 wks 2days 1 wk 2 wks 3 wks
Fetal
16-days - 4 4 4 - 4 4 4
19-days 16(6)2 - 15(5) 16(4) - - -
20-days 7(3) 9(5) 10(5) 9(4) .
Neonatal
2-days - 4 4 4
4.2 Controls
The controls used in the study were unseeded DHT cross-linked and EDAC cross-
linked type I collagen-GAG matrices. Matrices were fabricated, cross-linked, and pre-
hydrated as described in Chapter 3. Unseeded matrices were then incubated and
z PI refers to passage 1 or the secondary cell culture derived from the primary cell culture after one
subculture.
2 Number of cell-seeded constructs allocated for DNA analysis appears in parentheses.
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cultured in agarose-coated tissue culture plates with complete media at 37C, 5% CO2.
Media was changed every 2 days. At the end of each time point, control matrices were
fixed and stained for histological study. The pore structure and degradation of the
matrices can be seen in Figures 5-10. Average pore size of matrices is tabulated in
Table 4. Over time, matrices degraded by hydrolysis. Macroscopically, matrix diameter
decreased over time. However, matrix pore size decreased from I week to 2 weeks in
culture due to scaffold shrinkage and then pore size increased after 3 weeks in culture due
to degradation of the collagen-GAG matrix (Table 4). Differences between DHT cross-
linked matrices and EDAC cross-linked matrices are less significant than differences
between prehydrated and dry DHT cross-linked matrices. Average pore sizes of dry
DHT cross-linked matrices are larger than prehydrated DHT cross-linked matrices at 1, 2,
and 3 weeks. However, the difference in average pore size is not significantly different at
the 95% confidence level using a Fisher's LSPD analysis.
After I week in culture, pore sizes of DHT cross-linked (Figure 5) and EDAC
cross-linked (Figure 6) matrices remain uniform. After 2 weeks in culture, pore sizes of
EDAC cross-linked (Figure 8) matrices enlarge while DHT cross-linked (Figure 7)
matrices diminish. This correlates with the decrease in scaffold diameter over time. By 3
weeks in culture, differences are even more significant (Figure 9, 10). EDAC treatment
following DHT treatment maintains pore structure and architecture. A separate study
was conducted to observe differences between DHT cross-linked matrices that were not
prehydrated before incubating and culturing (Figures 11-13). The scaffold
characteristics of these matrices differ from prehydrated DHT cross-linked matrices and
appear similar to EDAC cross-linked matrices. Average pore sizes of dry DHT cross-
linked matrices are larger than both prehydrated DHT and EDAC cross-linked matrices.
Pore sizes of matrices were characterized and results are tabulated below.
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Table 2 Average pore diameter calculated using linear intercept method for DHT cross-linked and
EDAC cross-linked matrices at 1, 2, and 3 weeks. N=1. 1251
Matrices Tvpe
Prehydrated DHT cross-linked
Prehydrated EDAC cross-linked
Dry DHT cross-linked
Time
I week
2 weeks
3 weeks
1 week
2 weeks
3 weeks
I week
2 weeks
3 weeks
Average Pore
Diameter
111 pm
102pm
108pam
112pm
102pm
105 am
120pm
115pm
155tm
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Figure 5 DHT-treated type I collagen-GAG
scaffold after I week in culture. H&E; 100X.
Figure 7 DHT-treated type I collagen-GAG
scaffold after 2 weeks in culture. H&E; 100X.
Figure 6 EDAC-treated type I collagen-GAG
scaffold after I week in culture. H&E; 100X.
Figure 8 EDAC-treated type I collagen-GAG
scaffold after 2 weeks in cultures. H&E;
100X.
Figure 9 DHT-treated type I collagen-GAG matrix Figure 10 EDAC-treated type I collagen-
after 3 weeks in culture. H&E; 100X GAG matrix after 3 weeks in culture. H&E;
100X.
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Figure 11 DHT-treated type I collagen-GAG scaffold Figure 12 DHT-treated type I collagen-GAG scaffold
after 2 days in culture. Scaffold was not after 2 weeks in culture. Scaffold was not
prehydrated. H&E; IOOX. prehydrated. H&E; 100X.
Figure 13 DHT-treated type I collagen-GAG scaffold
after 3 weeks in culture. Scaffold was not
prehydrated. H&E; OOX.
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4.3 Scaffold Contraction
A two factor ANOVA analysis and Fisher's LSPD are used to determine the
effect of cell-seeding on scaffold contraction. Cell-seeded scaffolds were found to have a
significantly smaller mean scaffold diameter compared to unseeded controls (p < 0.0001;
Power = 1) (Figure 14). This difference was also significant at every time point except
during the initial seeding period (0 days). Mean measured diameter for 19-day fetal cell-
seeded scaffold was 5.3±1.7mm and 6.1+1.0mm for unseeded controls. Mean scaffold
contraction was 34.0% and 23.7% for 19-day fetal cell-seeded and unseeded collagen
scaffold respectively. Scaffold contraction was not found to be significant for 20-day
fetal rat lung cells (p = 0.5437). Mean scaffold contraction was 9.9% and 13.2% for
unseeded controls and 20-day fetal cell-seeded scaffold respectively. Mean scaffold
diameter measured for 20-days gestation fetal cell-seeded scaffold was 6.6±0.7mm and
6.3±0.9mm for unseeded controls. Scaffold contraction was highly significant (p <
0.0001) for 2-day neonatal cell-seeded scaffold compared to unseeded controls. Mean
diameter of neonatal cell-seeded and control scaffolds were 4.92±2.4mm and
6.2±0.35mm respectively. At the end of three weeks, 16-day, 19-day, 20-day fetal, and 2
days neonatal cell-seeded scaffolds had contracted to 68%, 42%, 73%, and 25% of
original scaffold diameter respectively compared to 72% contraction of unseeded
scaffolds (Figure 15). Therefore, cell-mediated contraction at the end of three weeks in
culture for 16-day, 19-day fetal and 2 days neonatal cell-seeded scaffolds were 4%, 30%,
and 47% respectively while there was no cell-mediated contraction in the 20-day fetal
cell-seeded study.
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* control
* fetal 16d
[ fetal 19d
E] fetal 20d
[ neonatal 2d
1- 0 days 2- 9 days 3-14 days 4- 21 days
Figure 14 Bar plot of percent contraction of original scaffold diameter of unseeded, 16-days, 19-days,
20-days gestation, and 2-days neonatal cell-seeded scaffolds after 0, 9, 14, and 21 days in culture.
Error bars represent one standard deviation with a 95% confidence interval. NcontroI = 42, Nl6dnys=
12, N!9.days= 35, N20-days= 34, N.days = 12.
73%ii m__ -68%
~~___ 8 8 
0 , _
2
time (weeks)
31
- Control
- ----. Fetal 16d
-*- Fetal 1 9d
-- Fetal 20d
- Neonatal 2d
4
Figure 15 Line plot of scaffold contraction for control, 16-day, 19-day, 20-day fetal and 2 days
neonatal rats seeded in DHT-treated type I collagen-GAG matrix cultures up to 3 weeks. Scaffold
contraction for control at 3 weeks was 72%.
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4.4 Mice Lung
The photomicrographs below are tissue sections from 10-day-old mice lung.
Sections are stained using hematoxylin and eosin stain, elastin stain, anti-smooth muscle
actin antibody immunostain, and anti-cytokeratin antibody immunostain. The respiratory
unit of the lung can be seen in Figure 16: alveolar ducts open into alveolar sacs and
alveoli. The respiratory bronchiole tissue and pseudostratified columnar epithelium
characteristic of the respiratory system is seen in Figures 17-19. The lung tissue is rich
in elastin (Figure 18) and actin (Figure 17), particularly the respiratory bronchiole tissue.
Mice lungs were negative for monoclonal mouse anti-cytokeratin antibody (Figure 19).
AndtC
', I
Figure 17 Photomicrograph of lung sectionFigure 16 Photomicrograph of lung section from 10-day-old mice. The red representsfrom 10-day-old mice. H&E; 200X.
PU(SIar V Sow 1 I U 3IIUU l III 1IClEaI.
(arrow). SMA; 100X.
Figure 18 Photomicrograph of lung section Figure 19 Photomicrograph of lung section
from 10-day-old mice where elastin tissue is from 10-day-old mice stained for cytokeratin.
stained black. Positive staining can be seen in Positive staining can be seen in the alveolar
the alveolar cells. Elastin; 200X. cells. Cytokeratin; 200X.
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4.5 Mice study
In both studies conducted, very few cells were observed by H&E staining. In the
first study, 326 million cells were obtained from 13 mice or roughly 25 million
cells/mouse. However, this large number reflects all the cells in the sample including a
lot of red blood cells. Unfortunately. the cell counting method does not differentiate
between different types of cells. These cells were frozen for a week before cell-seeding.
During the time of seeding, only 120 million cells remained viable. In the second study,
we attempted to isolate alveolar epithelial cells in the cell population and remove
fibroblasts and other cells by differential adherence. Using this method, 23 million cells
were obtained from I mice or 2.09x 1 06cells/mouse. Samples of the cells and matrix
were stained with H&E and examined using light microscopy. The cells did not appear
to adhere to the collagen matrix. The few cells that were found within the matrix were
concentrated at the scaffold perimeter and poor viability was observed. These
observations were true for both DHT-treated and EDAC-treated matrices. No significant
difference was found between the two types of matrices.
i-
4.6 Fetal Rat Lung
Lung tissue from 19-days-gestation fetal rats are sectioned and stained with
hematoxylin & eosin (Figure 20) and elastin stain (Figure 21). The lung tissues of the
fetal rats are very rich in cells whereas very little extracellular matrix tissue is observed at
this stage. The cells appear in morphology similar to cuboidal type II alveolar cells.
Figure 20 Photomicrograph of 19-days- Figure 21 Photomicrograph of 19-days-
gestation fetal rat lung. H&E; 200X. gestation fetal rat lung. Elastin stain; 200X.
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4.7 Neonatal Study
In this study, alveolar-like structures were not present. After one week in culture,
most of the cells were located peripherally with fewer cells at the center of the scaffold
(Figure 22). Cells appeared stratified or pseudostratified in morphology at the perimeter
of the scaffold while cells within the scaffold remained cuboidal. After two weeks in
culture, more collagen secretions were seen through the collagen matrix and the cells at
the perimeter became more attenuated. Within the matrix, cells remained cuboidal,
undergoing growth and appear larger in size (Figure 23). After three weeks in culture,
the cells had developed into a stratified cuboidal epithelium (Figure 24). The samples
were fed media in a static culture. A cell-gradient of viability can be seen in Figure 25,
where the media and oxygen are diffusion-limited to the perimeter of the scaffold. Cell
apoptosis. cytoplasm, and nuclear fragmentation are observed within the matrix.
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Figure 22 Photomicrograph of perimeter of
neonatal cell-seeded scaffold after 1 week in
culture. H&E; 200X
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Figure 23 Photomicrograph of center of cell-seeded
scaffold after 2 weeks in culture. H&E; 200X.
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Figure 24 Photomicrograph of cell-seeded DHT-treated Figure 25 Photomicrograph of cell viability
scaffold after 3 weeks in culture. H&E; 100X gradient seen in scaffold after 3 weeks in culture.
H&E; 40OX.
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4.8 16 days gestation fetal study
No structural formation was found in the 16-days gestation fetal study. A total of
18.2xl 0 6cells was obtained from 12 fetuses with a cell viability of 94.6%. The cell-
seeding density used in the study was 2.3x10 6cells/matrix. Both DHT cross-linked and
EDAC cross-linked type I collagen-GAG matrices were used.
After 1 week in culture, the cells in the EDAC-treated scaffolds were largely
located in the perimeter. Cell morphology was attenuated at the perimeter but round and
cuboidal at the center. However, only a very sparse number of cells were observed in the
scaffold center and the beginning of scaffold degradation can be seen at the center.
On the other hand, after 1 week in culture, the cells seeded in DHT-treated
scaffolds were uniformly distributed along with many red blood cells throughout the
matrix (Figure 26). Contraction was also clearly evident and cells stain positively for
smooth-muscle actin antibody (Figure 27), but no actual alveolar-like structure is
present.
After 2 weeks in culture, the cells seeded in the EDAC-treated scaffolds are
observed mostly on one side of the matrix within 1mm thickness (Figure 28), while cells
seeded in the DHT-treated scaffolds mostly contain a lot of red blood cells with few other
cells (Figure .30).
After 3 weeks in culture, most of the cells seeded in EDAC-treated (Figure 29)
and DHT-treated (Figure 31) scaffolds have undergone apoptosis and only cell debris
and cytoplasm remain.
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Figure 26 DHT-treated matrix seeded with 16-
days gestation fetal lung cells after 1 week in
culture. H&E stain; 400X.
Figure 27 DHT-treated matrix seeded with 16-
days gestation fetal lung cells after I week in
culture. Cells have positive staining for SMA
(arrow). SMA stain; 200X.
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Figure 28 Photomicrograph of 16-i
fetal rats seeded in an EDAC-treat
matrix after 2 weeks in culture. H
" .'' . , ' .,- ,, t ; 
.. IJ;~ ':. ... '
.. ' ' ' ;" -'. ' \ .' · , -
.· ,S '.,, ., . .' ._ ' ' . . ', . .,,
ds. . -
*. ._'.; . .:. ... '..... i 4 ;
' .
*, * -0 Ih . - , i
ted collagen fetal rats seeded in an EDAC-treated matrix after 3
E; 400X. weeks in culture. H&E; 10OX.&rE; 400 . eeks in culture. ; 100X.
-1 . -'S
,,: :' - ' ' .. , r'
"- ~ ~ ~ ~ ~~~. . , - ~., .:-'S·
": A> -,~. '~i,.. 
· · < 
. .4 ' -
.
.
-i } *' ,d- 'S
,,,~ ~~~~~~~. -k .  "i ,.,. :?-' ". ''. '::. .,> , 4
·~ . - .. : ',
f/ -t ·pm: i " ..~. ~.
~..., - . ' -;h ,'..,..=:'"
' - " , ~ - -. ___.. '
Figure 30 Photomicrograph of cell-seeded DHT-
treated scaffold after 2 weeks in culture. H&E;
400X.
Figure 31 Photomicrograph of cell-seeded
DHT-treated scaffold after 3 weeks in
culture. H&E; 400X.
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4.9 20 days gestation fetal study
In the study performed using 20-days gestation fetal cells, no structural formation
was found. The cells were immunopositive for anti-cytokeratin antibody (Figure 32, 33)
but negative for smooth-muscle actin antibody (Figure 34). Even after week in culture,
loss of nuclei can be seen (Figure 35). By 3 weeks in culture, all cells had undergone
apoptosis (Figure 34).
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Figure 32 Photomicrograph of 20-days
gestation fetal lung cells seeded in DHT-
treated collagen matrix after 1 week in culture.
Cytokeratin stain; 200X
.. · of- ' I ..
Figure 33 Photomicrograph of 20-days gestation fetal
lung cells seeded in DHT-treated collagen matrix after
3 weeks in culture. Clear positive staining for
cytokeratin can be seen . Cytokeratin; IOOX.
Figure 34 Photomicrograph of 20-days gestation Figure 35 Photomicrograph of 20-days gestation
fetal lung cells after 3 weeks in culture. SMA; fetal lung cells seeded in matrix after 1 week in
IOOX. culture. H&E; 400X.
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4.10 19 days gestation fetal study
In the study performed with 19-days-gestation fetal rat cells, alveolar-like
structural formation was not found until after 2 weeks in culture. After 2 days post-
seeding, cells appeared uniformly monodispersed throughout a porous, well-intact
collagen-GAG matrix (Figure 36). After 2 weeks in culture, alveolar-like structures
were found localized at the edges and perimeter of the scaffolds where cell density was
higher (Figure 37). Some but fewer ALS were located in the middle of the matrix
(Figure 37). Structures found after 2 week in culture are alveolar-like for the following
reasons: 1) the cells comprising the structures are cuboidal with apical-basal polarity and
microvilli on their apical surface (Figure 37) resembling type II alveolar cells found in
the alveoli of the lung in vivo, 2) the structures abut the collagen matrices basally and
form a central lumen apically basally as observed in the tissue section stained with
Masson Trichrome (Figure 39) and is similar to the architecture of the normal in vivo
alveoli, 3) alveolar-like structures are surrounded by tissue positive for smooth-muscle
actin (Figures 42-43) which is also found in the adult lung tissue (Figure 17), 4) cells
appear to secrete pulmonary surfactant characteristic of type II alveolar cells (Figure 40),
5) the cells that compose the structures contain cytokeratin, an intermediate filament only
present in alveolar cells in the lungs (Figure 44), and 6) elastin is abundantly present in
the structures (Figure 45) as was also found in the adult lung tissue (Figure 18). These
alveolar-like structures were maintained up to 3 weeks in culture (Figure 38, 40, 41).
When cells were seeded onto dry matrices, no structural formation was observed.
After 2 days, cells were distributed non-uniformly with a concentrated aliquot of cells in
the middle of the matrix where it had been initially seeded (Figure 46). Cells were
viable after 2 weeks in culture but no alveolar-like formation was found (Figure 47).
Minimal interaction was observed between the collagen matrix and the cells even after 3
weeks in culture (Figure 48). This is also verified by the lack of scaffold contraction in
culture after 3 weeks (results not shown). In a photomicrograph of the thickness of the
cell-seeded scaffold after 3 weeks in culture. cells remained seeded on one side of the
matrix and minimal cell migration and activity was observed (Figure 49).
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Figure 36 Photomicrograph of 19-days gestation
cell-seeded scaffold after 2 days in culture. The
cells are monodispersed within the collagen
matrix. H&E stain; X200.
Figure 37 Photomicrograph of 19-days gestation
cell-seeded scaffold after 2 weeks in culture. Two
arrows each point to alveolar-like structures.
Pulmonary surfactant secreted by the cells can also
be seen. H&E stain; X200.
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Figure 38 Photomicrograph of cell-seeded scaffold Figi
after 3 weeks in culture. The arrow points to a afte
growing alveolar-like structure. H&E stain; X200. thre
and
alve
ire 39 Photomicrograph of cell-seeded scaffold
r 2 weeks in culture. Masson trichrome stain is a
ee dye stain that stains collagen blue, nuclei black,
cytoplasm red; X200. The arrow points to an
eolar-like structure.
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Figure 40 Photomicrograph of cell-seeded scaffold
after 3 weeks in culture. Arrow points to
surfactant secretion. H&E; 200X.
Figure 42 Photomicrograph of ALS with positive
SMA stain around structure. SMA; 200X.
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Figure 41 Photomicrograph of cell-seeded scaffold
after 3 weeks in culture. H&E; IOOX.
Figure 43 Photomicrograph of ALS surrounded
with positive SMA (arrow). SMA; 400X.
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Figure 44 Photomicrograph of type II alveolar cells
with positive cytokeratin intermediate filament
staining in cytoplasm(arrow). Cytokeratin; 1000X.
Figure 45 Photomicrograph of ALS stained for elastin
after 2 weeks in culture. Elastin; OOX.
Figure 46 Photomicrograph of 19-days gestation Figure 47 Photomicrograph of 19-days gestation cell-
cell-seeded scaffold after 2 days in culture. seeded scaffold after 2 weeks in culture. H&E; 10OX.
H&E; OOX.
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F igure 48 Photomicrograph of 19-days gestation cell- Figure 49 Photomicrograph of scaffold thickness of
seeded scaffold after 3 weeks in culture. H&E; IOOX. 19-days gestation cell-seeded scaffold after 3 weeks in
culture. H&E; 100X.
4.11 DNA Assay
Results from the pico-green DNA assay show a decreasing amount of DNA and a
decreasing cell number in cultures with time. Results for the cell number (mean+SD) in
culture for 19-days gestation and 20-days gestation fetal studies are shown below.
Figure 50 Bar graph (mean + st. dev) of 19-days gestation cell number at 2, 14, and 21 days in
culture. N2 days = 6, N1 4 days = 5, N2 1 days 4.
19 days gestation
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Figure 51 Bar graph (mean ± st. dev) of 20-days gestation cell number at 2, 14, 21 days in culture.
N2 days= 3, Nldys = 5, N14-days= 5, N21-days = 4.
20 days gestation
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4.12 Collagen-GAG Assay
From the collagen-GAG assay performed, very little GAG was produced in the
cultures.
4.13 Quantification of Alveolar-like Structures
Only alveolar-like structures were found in the DHT-treated type I collagen-GAG
scaffolds seeded with 19-days gestation fetal rat cells. No alveolar-like structures were
found up to 1 week in cultures. Alveolar-like structures were found in cultures at 2
weeks and 3 weeks. An ANOVA analysis of the ALS shows no significant difference in
the size of the structures between week 2 and week 3. The average ALS at 2 weeks and 3
weeks was 52.5+24.9ipm and 60.2±33.2,tm (mean i SD) (Figure 52). In the samples
analyzed, a total of 30 ALS and 28 ALS were found at 2 weeks and 3 weeks. A Fisher's
PLSD analysis for average ALS found no significant difference between week 2 and 3
(p=0.3969). Average number of ALS found was 10.4/mm 2 and 9.8/mm2 after 2 weeks
and 3 weeks in culture respectively. The largest structures found after 2 weeks and 3
weeks in culture were 130gm and 160pm in diameter respectively.
The form factor is an aspect ratio that defines the shape of the alveolar-like
structures. A perfectly circular ALS has a form factor of 1 while elliptical structures and
deviations from round structures are between 0 and 1 (Figure 53). The average form
factors after 2 weeks and 3 weeks in culture were 0.7±0.2 and 0.6± 0.2.
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Figure 52 Bar graph of average size of alveolar-like structure after 2 weeks and 3 weeks in culture.
No structures were found in scaffolds after 2 days in culture. Study was terminated after 3 weeks.
N2wek,= 30, N3Wek.= 28.
Cell Bar Chart
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Figure 53 Form Factor calculated for alveolar-like structures after 2 weeks and 3 weeks in culture.
A slope of 1 indicated a round structure.
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Chapter 5 Discussion & Conclusion
5.1 Development of a cell isolation procedure whereby cells are
enzymatically dissociated from fetal and neonatal rat lungs while
maintaining cell surface receptors which are critical in regeneration of
lung structures.
A careful cell isolation procedure is critical to the maintenance of cell surface
receptors needed for regeneration of lung structures. Enzymatic dissociation of lung
tissue is performed in a series of steps and filtered through different pore-size meshes to
obtain a final monodispersed cell suspension. Cells are chilled on ice to slow down
cellular metabolism during lung cell isolation.
The cell-to-cell interactions involved in the reaggregation process and structural
formation require cell membrane bound macromolecular components similar to those
described in the embryo cells. Proteolytic treatment disrupts specific cell-ligand
components, and if reaggregation is to occur, these structures must reform. Incubation of
cell pellet before cell-seeding is believed to allow resynthesis and the formation of cell
surface components.
The use of primary cells is also important to lung tissue regeneration. The lung is
a complex organ composed of a diverse cell population. Type II cells plated on tissue
culture plastic dedifferentiate and inhibit the formation of lung structures. In studies
performed by previous investigators, the tissue digestion and cell isolation procedure
were performed to obtain a high yield of type II alveolar cells and alveolar-like structures
were also observed. In all cases however, the use of a primary cell population was
needed for in vitro formation of alveolar-like structures.
The procedure developed in this study maintains the surface receptors of 19-days
gestation type II alveolar cells and promotes the formation of alveolar-like structures in
our in vitro system.
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5.2 Identification of fetal and neonatal lung cell behavior differences
using histological analysis.
From analysis of the studies performed, differences have been observed between
fetal and neonatal lung cell behavior. We have found no alveolar-like formation with
neonatal lung cells from Sprague-Dawley rats or mice. In addition, alveolar-like
formation was not found using lung cells from fetal Sprague-Dawley rats at 16-days
gestation and 20-days gestation. Alveolar-like structural formation was only found using
a cell source from 19-days gestation fetal rat cells. Results from this study suggest that
alveolar formation in lungs occur at 19-days gestation when cultured in our in vitro
system. It also appears that only at 19-days gestation do cells express the necessary cell
receptors for reaggregation into alveolar-like structures in vitro. These results differ from
work done by other investigators where structural formation was observed with different
gestation fetal [12] and adult rat lung cells [10]. Further investigation will have to be
done to determine whether differences are due to our in vitro system or to variances in
cell isolation and culture methods.
Other significant differences found between fetal and neonatal lung cells are
smooth muscle actin expression and collagen-GAG matrix contraction. The presence of
smooth muscle actin is found in greater amounts in neonatal cells compared to fetal cells
and correlate with differences in scaffold contraction observed over time. Samples
seeded with neonatal lung cells were found to contract significantly more over time
compared to scaffolds seeded with fetal lung cells. This phenomena is analogous to the
change seen in wound healing process from skin regeneration in the fetus to fibrous scar
formation in the adult described by Yannas [26].
Cell-matrix interactions dominate in the neonatal cell culture system. In fetal cell
culture system, cell-cell interactions dominate. The presence of alveolar-like structures is
only found in fetal cells while pulmonary surfactant synthesis is found in both fetal and
neonatal alveolar cells. The difference in cell behavior between neonatal and fetal lung
cells can be explained by a difference in cell surface receptor expression. This is
supported by observed differences in lung architecture between the fetal lung and
neonatal lung. The respiratory portion of the fetal lung comprises almost entirely of
alveolar cells while in the neonates and adults, all the alveolar cells underlie an
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extracellular matrix. The extracellular matrix components are partially secreted by the
alveolar cells. This correlates with completion of alveolar formation which occurs during
late gestation after epithelial cells differentiate into type I and type II alveolar cells.
5.3 Investigation of the effects of selected scaffold design variables on
lung tissue regeneration in our in vitro system.
The type I collagen-GAG scaffold is an appropriate extracellular matrix analog
for lung tissue regeneration. Collagen is found abundantly in the native lung and
functions to provide support. In the alveolus and small airways, collagen is found in the
interstitium and basement membrane. Type I collagen constitutes a large portion of the
collagen found in the lung and thus provides most of the lung tissue support. In the lung,
type I alveolar cells predominantly overlie capillaries where the matrix is mostly type IV
collagen and laminin, whereas type II alveolar cells are usually found in corners where
there is an additional matrix component of type I collagen. The lung cells that have been
found to secrete type I collagen are largely classified as mesenchymal cells. These cells
have similar morphology and include fibroblasts, interstitial cells, contractile cells, and
pericytes. The collagen scaffold lacks type III collagen also known as fetal lung named
after its finding at higher amounts in younger animals. Type IV collagen is the primary
collagen found in basement membranes and thus believed to anchor epithelial and
endothelial cells. Since our study only has type I collagen, we only observe type II
alveolar cells. Type I alveolar cells are not observed due to the lack of necessary matrix
components such as type IV collagen. Type II cells are also not observed to
differentiated into type I cells at the end of 3 weeks in culture. A longer culture period
can be performed to determine whether type II cells differentiate to type I cells over a
longer time.
In this study, dehydrothermally (DHT) cross-linked type I collagen-GAG matrices
were used which are structurally similar to the Gelfoam sponges previously used except
suitable for tissue engineering. The collagen-GAG matrix should produce an
environment which facilitates cell-cell contact and provide adequate media supply
making it conducive to aggregate formation. The sponge-like structure with its random
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trabeculae is expected to promote the formation of numerous individual aggregate
elements by compartmentalizing the cell inoculum without obstructing cell movement.
The main advantage of using a three-dimensional lattice culture is so that the cells can
easily migrate through the flexible matrix and find their nutrients inside the collagen
scaffold both by their apical and basal surfaces. The process of alveolar-like formation
appears to be closely dependent on the fact that both basal and apical sides of the
epithelial cells are covered by collagen. The process of tubule formation may be due to
either the physical properties of the lattice which possess a loose and flexible fibrillar
structure or secondary to the interaction of the cell surface integrin receptors with
collagen [27].
EDAC cross-linked scaffolds did not allow reaggregation of cells into ALS.
Chemically cross-linking scaffolds prevented cells to contract scaffold and aggregate
together. EDAC cross-linked scaffolds also degrade at a slower rate compared to DHT
cross-linked scaffolds. Formation of ALS appears to depend on cell contraction of
scaffold, followed by degradation of matrix, and formation into aggregates.
When matrices were not prehydrated before cell-seeding, structural formation was
also not observed. In fact, there was minimal activity observed due to the inability of the
cells to infiltrate into the matrix and adhere onto the collagen matrix surface. Cells
cannot proliferate, migrate, and synthesize without adhesion to the extracellular matrix
via cell-surface molecules known as integrins. It appears from the study that cell-cell
interactions are also prohibited by the lack of cell-matrix interactions. Therefore, no
aggregation or alveolar-like formations were observed even after three weeks. After
three weeks in culture, the cells were still poorly distributed and no cells were evident on
the bottom portion of the matrix. From this study, we confirm that both cell-matrix and
cell-cell interactions appear critical for the formation of alveolar-like structures and that
the process of prehydrating the matrix before cell-seeding allows the matrix to swell and
allows cells to migrate into the matrix and adhere onto the matrix surfaces. It seems that
while cell-cell interactions are critical to the formation of alveolar-like structures, cell-
matrix interactions play a key role preceding this event.
Alveolar-like structural formation was found using collagen-GAG scaffolds of
mean pore size 95.9gpm (dry). This pore size was large enough to allow cell migration
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into scaffold and aggregation into alveolar-like structures. However, we have found that
scaffold pore size does not appear to have a significant effect on the formation of
alveolar-like structures. It is only important that the pore size be large enough to allow
cells migration into scaffold and nutrients diffusion through scaffold.
5.4 Investigation of lung cell behavior revealed as the cells interact with
an analog of the extracellular matrix.
Results from the studies carried out also reveal that cell source and age may play
an important role in the formation of alveolar-like structures. Structural formation was
not found using neonatal cells from mice or rats nor from 16-days or 20-days gestation
fetal rat lung cells. Structural formation was only found when collagen-GAG matrices
were cultured with 19-days gestation fetal lung cells. Our results differ from results
concluded by Sorokin who found that formation of alveolar-like structures depended on
time spent in culture rather than with gestational age of cells used. It was concluded that
cells of different gestational age differentiated at similar rates when cultured in vitro [28].
There are several explanations for why there were no structural formations in the
study using lung cells from mice. One possibility is that lung cells from mice have
different surface receptors from rats and do not recognize the ligands on type I collagen
matrix surfaces. This is supported by the finding that there was minimal interaction of
the cells with the matrix. However, there was also very little cell-cell interaction found.
Another possibility is that cell surfaces were damaged during the isolation and freezing
procedure. A more likely possibility is that cells had dedifferentiated after plating. It
appears that the use of primary cells is critical for structural formation. The effect of lung
cells from different species of animals (mice vs. rats) in the formation of lung structures
remains unclear and will have to be further investigated.
From the results found through the histological studies and DNA assay, cells are
not proliferating over time. Even in the presence of alveolar-like structural formation and
maintenance of structures up to 3 weeks, the cell number in our cultures decreased over
the 3 weeks in our study. Interestingly, the ALS observed were localized in their area of
formation. Most structures were found peripherally of the matrix and in the center of the
matrix where there was massive degradation of the matrix. Only a few structures were
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found deeply embedded within the matrix. These observations suggest that factors such
as oxygen and specific matrix architecture determine not only alveolar-like structural
formation but also cell apoptosis. From our results, it appears that while structures were
maintained over three weeks, the remaining cells in culture underwent apoptosis over
time. It is possible that alveolar cells may be programmed for alveolar formation so that
cells not participating in alveolar formation undergo programmed death. The formation
of structures at sites of maximum oxygen and nutrient exchange mimics the in vivo lung
architecture where carbon dioxide and oxygen gas exchange occurs continuously through
the tissue.
Contractile properties exhibited by the type II alveolar cells and the contraction of
the substratum is believed to promote the formation of the alveolar-like structures.
Contraction of the collagen-GAG scaffold allows type II cells to remain cuboidal in
shape rather than attenuating and dedifferentiation and thus represents an environment
similar to one in vivo. When type II cells are cultured on tissue culture plastic in the
presence of 5 - 10% FBS, cells undergo extensive morphological changes which include
lost of cuboidal appearance, cell flattening, decrease in size and number of lamellar
bodies, and dramatic decrease in surfactant synthesis. In a three-dimensional collagen-
GAG scaffold, type II cells appear to maintain morphologic characteristics of type II cells
in vivo - i.e. apical-basal polarity, basal lamina secreted and formed, and well-developed
junctional complexes.
5.5 Theory for the formation of alveolar-like structures
Several theories for the formation of alveolar-like structures can be postulated
from analysis of the results in this thesis. An alveolar-like structure is defined in this
study as a structure composed of cuboidal type II cells which attach onto the type I
collagen-GAG matrix and form via intercellular junctional complexes into a structure
with a central lumen resembling an alveolus. These structures may or may not have
pulmonary surfactant secreted apically by the type II cells into the lumen.
The first theory for the formation of ALS is by spontaneous aggregation of
structures. Cells attach via integrins to the type I collagen-GAG matrix and migrate
through the pores forming cell-matrix interactions. Cells contract the scaffold exhibiting
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smooth muscle-actin phenotype in order to form cell-cell interactions. This process is
repeated over time resulting in the final formation of an alveolar-like structure composed
of type II alveolar cells. Evidence that supports this theory includes our results for the
correlation of cell-mediated contraction and ALS formation and the lack of ALS found
when there was minimal contraction observed. Growth of structures and formation of
more structures can occur by two possible ways. The first method is by division of a
large tubular structure into smaller structures. This process is clearest in histological
samples after 3 weeks in culture in scaffolds seeded with 19-days gestation fetal lung
cells. Structures can initially form from a dense aliquot of type II alveolar cells. As cells
undergo mitosis, growth, and apoptosis, this can result in the formation of tubular
structures. Evidence in support of this theory is in the observation of cell apoptosis at the
center of the alveolar-like structures. The second method is by addition of smaller
structures into larger structures. It is unclear from examination of the fixed tissue
sections the direction of growth. It is therefore just as likely that small alveolar-like
structures coalesce together to form larger structures since there was no statistically
significant difference found between the sizes of the ALS at 2 weeks and 3 weeks. In
either case, the development of apical-basal polarity is evident by the secretion of
pulmonary surfactant into the lumen of the alveolar-like structures from the apical surface
of the epithelial cells.
Reconstruction of ALS from type II alveolar cells in a three-dimensional collagen
matrix in culture occurs when the cell surfaces are in contact with the collagen matrix and
in the appropriate physiological environment for cellular and structural differentiation. In
other words, cell receptors play an essential role in the cellular differentiation and allow
cells to communicate with the ECM towards structural differentiation. The findings here
suggest that alveolar type II cells are self-differentiating cells and the type I collagen-
GAG matrix supports the expression of differentiation. It appears that the maintenance of
cell polarization in a thick three-dimensional substrate is important to surfactant
synthesis, cell differentiation, phenotype preservation, and structural formation.
In conclusion, the formation of alveolar-like structures is found after 2 weeks in
culture using 19-days gestation fetal rat lung cells and the ALS are maintained up to 3
weeks in our in vitro system. Several conclusions can also be inferred from the results of
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studies performed using different cell sources and scaffold types. The results indicate
that cell source appear to be critical to the formation of alveolar-like structures for our in
vitro system. Structural formation was found only with 19-days gestation fetal rat lung
cells. From our results, DHT cross-linked type I collagen-GAG scaffold is a suitable
analog for lung tissue regeneration. In terms of the characteristics of the scaffold, it was
found in the study that contraction of the scaffold was necessary in the formation of ALS.
The characteristic pore size of the scaffold did not appear to affect lung tissue
regeneration. The contraction of scaffold and expression of smooth muscle actin both
play important roles in the fetal formation of alveolar-like structures. ALS was found in
prehydrated DHT cross-linked scaffolds and not in EDAC cross-linked scaffolds or dry
DHT cross-linked and therefore supports our belief that reaggregation of cells and the
formation of cell-cell and cell-matrix interactions is critical in the formation of alveolar-
like structures.
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Chapter 6 Limitations and Future Work
6.1 Limitations
There are still many challenges to overcome in lung tissue engineering. The lung
is an organ with a very unique and complicated architecture made up by a wide variety of
highly differentiated cells. In fact, the lung parenchyma, airways, and pulmonary
vasculature together have 40 different cell types. The unique architecture of each
capillary vessel surrounded on both sides by one cell-thick epithelium needed to
maximize efficiency of carbon dioxide-oxygen exchange is probably the greatest obstacle
towards successful lung tissue engineering. This problem cannot be resolved until we
know how to control and direct angiogenesis to create the intricate pulmonary
vasculature.
In terms of limitations within this study, the results found only apply to a limited
animal study performed in vitro. Results of this study need to be applied to larger
animals and ultimately to the human lung in vitro and in vivo. Results found were also
only applicable and limited to fetal and neonatal rat lung cells and no conclusions were
made about the behavior of adult lung cells. All the results and conclusions were
primarily based on analyses from histological sections.
The method described in this thesis for isolation of lung cells to maintain cell
surface receptors and allow formation of alveolar-like structures may not be applicable to
adult alveolar cells or to cells of different species. Investigation into a cell isolation
procedure which maintains cell surface receptors in neonatal and adult lung cells is
necessary for applications of this work clinically.
6.2 Future work
Type II alveolar cells should be verified by use of scanning electron microscopy
to observe the osmiophilic lamellar bodies responsible for pulmonary surfactant
production. Pulmonary surfactant secreted by type II alveolar cells can be used as a
biochemical marker of differentiated type II cell phenotype. The major active component
of the surfactant, dimpalmitoyl-phosphatidylcholine (PC), can be radioactively labeled
through incorporation of [Me-3He]choline into PC [11 ]. Immunocytochemical methods
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can also be used to identify the surfactant proteins, SP-A, SP-B, SP-C. Alternatively, rat
alveolar type II epithelial cells can also be identified using a tannic acid and polychrome
stain [29]. Cell proliferation in culture can be examined using bromodeoxyuridine
(BrdU) labeling reagent to investigate the behavior of cells.
The addition of growth factors and hormones into the media can enhance
differentiation and growth of cells into histotypic structures or ALS. In previous work,
the addition of various hormones was found to affect the branching morphogenesis of
lung structures and the production of surfactant lipids. Differentiation and proliferation
can be accelerated by treatment with dexamethasone [16] and thyroxine. Epidermal
growth factor is also found to increase growth of structures. Others found transforming
growth factor-beta to play a role in organizing cells into histotypic structures.
Future studies could also use both type I and type IV collagen in the scaffold as a
better analog to the connective tissues and extracellular matrix of the lung. Only type I
collagen was used as the ECM analog and for this reason, type I alveolar cells were not
found in the in vitro system. The differentiation of type II cells into type I cells remains
to be clarified. The use of laminin-coated matrices has also been found to promote
retention of the cuboidal shape of type II cells and the role of laminin can be further
investigated.
The bioreactor plays a very important role in successful lung tissue engineering
and was not heavily explored. Future work could include the use of a bioreactor that
mimics the environment in the lung which involves expansion and deflation of the lung
parenchyma and variable oxygen and carbon dioxide diffusion through lung tissue.
Some initial work investigating the interaction between mesenchymal and
epithelial cells has been done [30]; however, the use of cocultures has not been applied
for lung tissue engineering. Results have been promising, particularly in the liver, in
tissue engineering using cocultures of cells. The use of cocultures of mesenchymal cells
and alveolar epithelial cells may result in a tissue more similar to the lung in vivo.
Just a few years ago, virtually no one thought lung tissue engineering was a
possibility. Results from this thesis now verify the potential for lung tissue engineering
and hopefully opens up an exciting area of research with great possibilities.
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Appendices
A.1 Pulmonary Surfactant
Pulmonary surfactant plays a very important role for normal lung function. The
main function of pulmonary surfactant is to lower the surface tension in the lung. It is a
major reason for the hysteresis in the lung pressure-volume curve. In the lung, surfactant
reduces the surface tension from 70dynes/cm (surface tension of water) to 0-25
dynes/cm. By decreasing surface tension, the driving forces for instability are greatly
diminished during deflation. During inflation however, the surface tension rises from 0
to 25dynes/cm explaining the hysteresis and the shape of the inflation curve. Other
functions of surfactant are to reduce the load on the respiratory muscles, improve
stability, and "waterproof" the alveoli. The size and shape of the alveoli make them
inherently unstable to interfacial surface forces since air seeks out the largest radius of
curvature. According to Laplace's Law (AP = 2a/a ), as the size of the alveoli get bigger
(a increases), the decrease in pressure would increase the disequilibrium so that the lung
would always be at a highly non-uniform equilibrium state. In normal lungs, four major
mechanisms allow the lungs to inflate uniformly and overcome the intrinsic tendency of
surface forces to drive the lung to instability and highly non-uniform states of inflation.
These are geometry, tissue forces, surfactant, and elastic interdependence.
Pulmonary surfactant is primarily produced by the type II alveolar cells.
Surfactant is secreted as lamellar bodies that reorganize into tubular myelin. Tubular
myelin releases surfactant which includes primarily lipids (90-95% of surfactant), as well
as palmitic acid, fatty acid, and proteins (5-10%). The lipids are primarily dipalmitoyl
phosphatidyl choline (DPPC) with 7% phosphatidyl glycerol. There are four types of
proteins known so far that are found in surfactant: SP-A, SP-B, SP-C, SP-D. SP-A is a
28-36kDa protein and augments biophysical function with SP-B and is calcium
dependent. SP-B is much smaller, 9kDA, and preferentially located in the corners of
tubular myelin and increases the adsorption of phospholipids by 100 times. SP-C is also
a small protein (4kDa) and interacts with SP-B and plays a backup role. Finally, SP-D
plays an immunological role beyond the scope of this project. The proteins in the
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surfactant serve to help dispersion and adsorption of the surface components and
determine the structure of the tubular myelin.
Surfactant insufficiency increases surface tension and thereby increases the
critical opening pressures of the alveoli units. In Respiratory Distress Syndrome of
neonates, lungs are highly nonuniform and difficult to recruit. In fact, the pressures
required for lung inflation may be too high causing barotraumas to higher compliance
regions. Surfactant lowers surface tension and increases surface pressure. The work
needed to create a new surface would be low if surface pressure is high. The current
view of surfactant function is that at end-expiration, the DPPC monolayer is in a highly
compressed solid phase with high surface pressure and low surface tension making
energetics favorable towards creating a new surface. At early-inspiration, the solid
monolayer breaks apart and fractures into condensed "ice flows" of DPPC monolayers
between newly created surfaces lowering the surface pressure and increasing surface
tension. At mid-inspiration, the poorly soluble DPPC rapidly adsorbs to the new surface.
This surface has poor surface pressure and high surface tension due to the formation of
chunks and a multi-layered structure rather than a complete monolayer.
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A.2 Protocol
I. Materials
- 3 Sprague Dawley Timed-Pregnant Rat
i. Average 12 fetuses / mother
ii. 19-20 days gestation (term = 22 days)
- DHT matrices 8mm in diameter, stored in sterile water until ready for use
- Gelfoam (Pharmacia & Upjohn) gelatin sponges cut 10mm in diameter
and stored at 4°C in HBSS until ready for use.
- 4 Agarose-coated 12-well tissue culture plates
- CO2 gas for asphyxiation or dry ice
- Sterile Gloves - 3 for mother, 3 for fetuses
- 70% ethanol
- 3 autoclaved razor blade (1/mother)
- Forceps for microdissection - I straight for mother, 2 straight, 1 angled for
fetuses, 4 total - autoclaved
- Scissors for dissection - 1 for mother
- Paper towels
- Disposable bags
- Alcohol swipes to wipe forceps between dissection
- Hank's balanced salt solution - warmed - 2 bottles
- Serum-free F12K media with antibiotics chilled
- Complete F 12K media with antibiotics & 10% FBS warmed
- FBS warmed
- Ice bath & Ice tub
- 1000mm-Petri Dishes filled with HBSS - 1 for mother, 1 for fetus
- 100mm- Petri Dishes filled with serum-free media - /mother
- 1Occ syringes filled with HBSS for lavaging lungs
- 50ml Erlenmeyer BD tubes
- 6 CTC enzyme (1% chicken serum, 0.1% collagenase type I, 0.1% trypsin
in Hank's Balanced Salt Solution, filter sterilized and stored frozen -20°C)
30ml/ mother or dozen fetuses
- 6 RNase-free DNase 1000units (1000gl) - Promega
- Styrofoam lid with pins for dissection
- 3 funnels - 2 funnels 41 1m nylon mesh, 1 funnel 25gm mesh
II. Dissection
1. Sacrifice one mother at a time by CO2 asphyxiation (approximately 1-2
minutes)
2. Perform a hysterectomy and remove the fetuses from the uterus placing
them in a large Petri dish filled with HBSS.
3. Dissect the fetuses free of the placenta and attendant membranes, cut off
the umbilical cords, and place fetuses in a clean Petri dish with fresh
HBSS.
4. Pin down the fetus on Styrofoam lid, attaching one needle above the
throat, one at the lower abdomen, and one needle at each upper arm.
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5. Remove skin: using 2 straight forceps, grip skin at throat, pull skin apart,
and avoid piercing the chest wall.
6. Remove the rib cage without piercing heart.
7. Inject HBSS into the heart at the right ventricle to flush the lungs. They
should enlarge and lighten in color.
8. Remove the heart and set aside for discard.
9. Remove the lungs and place in Petri dish with serum-free F12K media.
Try to remove stray structures, especially bronchi.
10. After removing all the lungs of the fetuses, place dish with lungs on ice
and repeat with other mothers until all mothers and fetuses are dissected.
II. Tissue Homogenization and Digestion
1. Transfer the lung tissue to a clean Petri dish with chilled serum-free
media, leaving behind blood clots.
2. Place samples onto lid of dish, if necessary, remove excess liquid with 1 -
ml pipetter.
3. With razor blade, chop the tissue finely. If you have not removed the
bronchi, you will notice that the chopped tissue is difficult to separate.
Continue to chop until the tissue is well homogenized.
4. Add the sample to the tube of 30ml CTC enzyme solution/mother and
l000units of DNase - both prewarmed to 370C.
5. Incubate the samples at 37°C, shaking for 15minutes at 300rpm.
6. After the incubation, some digestion should be evident. Swirl the tube and
let the undigested tissue fragments settle.
7. Carefully draw off the dissociation fluid using 10-ml pipette and filter the
solution into a sterile 50ml conical tube using 1 layer of 41 Am mesh over
funnel.
8. Wash the tissue with 10ml of serum-free F12K media. Swirl the tube and
allow the fragments to settle then draw off the fluid and filter it through
the 41 gm mesh.
9. Add 1 Oml of complete media w/10% FBS (total volume now 50ml) to
inactivate collagenase and trypsin and pipette up and down to mix well.
Store the tubes on ice.
10. Add 30ml CTC enzyme solution and 1 000units DNase to remaining tissue
fragments and incubate samples at 37C, shaking for 1Smins at 300rpm.
After the incubation, the tissue should be complete digested - if tissue
remains should be connective tissue.
11. Filter the suspension through the 41 Am funnel. Wash the tube with 10 Oml
of serum-free F 12K media and filter that solution through.
12. Add I Oml of complete media w/10% FBS to inactivate enzymes (total
volume now 50ml) - total of 6 tubes - store on ice.
13. Centrifuge the homogenate for 10 minutes at 1500rpm.
14. Vacuum off the supernatant, keeping the cell pellet and resuspend each
tube by mild Vortex mixing.
15. Combine the contents of all the tubes into a single 50-ml centrifuge tube
by passing the suspension through a 25pm filter unit. Fill the tube to 50ml
with chilled complete media and mix well to wash cells.
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16. Equally aliquot 25ml cell suspensions to two 50-ml centrifuge tubes and
fill each tube to 50ml with chilled complete media.
17. Perform a viable cell count on one of the tubes via trypan exclusion.
18. Add 15p1 trypan blue to 151l cell suspension and perform cell count.
While counting, spin down original cell suspension at 1500rpm for 10
minutes.
19. Tcells = NTotal counted/(Nsquares counted) * 2* 1 0 4*Vmedia
20. Re-aliquot the cell suspension to 1.Oxl 07viable cells/50ml media
21. Centrifuge the tubes for 6mins at 1500rpm. Draw off and discard
supernatant leaving 50 - 1001 O of fluid overlaying.
22. Incubate the pellet with a thin layer of supernatant at 37°C for 1 hr. Warm
the agarose-coated plates in the incubator at 370C for 1 hr.
23. Following the incubation period, resuspend the cell pellet in medium to
give a final concentration of 108 cells/ml determine volume using a 5-ml
pipette.
24. Seed cells with a cell-seeding density of 5x I 06cells/matrix (minimum 1.0
x 106 cells/matrix).
25. Determine total volume needed and bring up cells in necessary volume
26. Inoculate each side of matrix with 20pl cell suspension or 20l1 complete
media for controls.
27. Place in incubator for 10 mins. Then flip matrices and inoculate other side
with 201tl cell suspension or 20gl complete media for controls.
(0.04ml/scaffold)
28. Incubate for 2-3 hours to allow cells to attach to the substrate, and then
add 0.5ml complete media to each well.
29. After 24 hours, add 1.5ml media to each well.
30. After 48 hours, cultures are placed on a rocker platform at a speed of 6
cycles per min.
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A.3 Standard Operating Procedure for Pore Characterization using
Linear Intercept Method [25]
Image Analysis:
1. Open the image in Scion Image
2. Click on Threshold in the Options menu. Select 'Options'; 'Threshold'; Slide red region
on the palette bar to optimize the selection of matrix struts without selecting pore space. If
a lot of background noise becomes black, go to the palette bar on the left and pull down the
threshold level until they disappear
3. Click on Binary under the Process menu. Click on Make Binary. The pixels will then be
assigned to black or white.
Pore Analysis:
1. Load the "pore characterization macros" by using Load Macros... under the Special menu.
Run Compute Percentage Area [P] under the Special menu. The % value in the little data
window is the black percentage of the area, which can be converted to porosity by subtracting it
from 100.
2. Select an area of the image with the oval drawing tool. To get a circle, hold the down the shift
key at the same time you are using the oval tool. Try to get as much of the image in the selected
area as possible.
3. Setting the Scale
1. Using a captured scale bar image at the same magnification from which matrix images
were captured and Set Scale from the Analyze menu, calibrate software
2. First, change the units to micrometers. In the measured distance box enter 1. In the
known distance box, enter the average value from the above table multiplied by 10-3.
(This last fixes the fact the program reports the distance values multiplied by 103.)
4. Run Linear Intercept under the Special menu. This will produce the pore radii at various
angles in the selected area. You must do this before you run the next macro. Run Plot Intercepts
in the Special menu. This will plot the pore radii at the various angle and the calculated best-fit
ellipse. Another window will give CO, C1, C2.
5. Transfer the CO, Cl, and C2 data to an Excel spreadsheet. It is a very long analysis to get to
the major and minor axes of the ellipse, but the resulting equations are:
1+a (1)
-- ~~~~oSJ~~~
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b = (2)
aspect ratio (AR) = a/b (3)
pore diameter = 3(a + (4)
The value '3' comes from 2 (converting radius to diameter) multiplied by 1.5 (multiplication
factor used to take into account the underestimate of pore diameter due to angle at which pore
was sectioned). The majority of pores will not be sectioned along their true cross-section, but
rather at an arbitrary angle which would skew their calculated pore size, this multiplication factor
corrects this underestimate.
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